SC
INO icon

Sculptor Capital’s Inovio Pharmaceuticals INO Stock Holding History

Sculptor Capital’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-59,467
Closed -$3.56M – 1267
2021
Q4 		$3.56M Hold
59,467
– – 0.03% 468
2021
Q3 		$5.11M Hold
59,467
– – 0.04% 324
2021
Q2 		$6.62M Buy
59,467
+33,900
+133% +$3.26M 0.05% 254
2021
Q1 		$2.85M Buy
25,567
+12,742
+99% +$1.68M 0.02% 378
2020
Q4 		$1.36M Hold
12,825
– – 0.01% 323
2020
Q3 		$1.78M Sell
12,825
-22,242
-63% -$4.64M 0.01% 241
2020
Q2 		$11.3M Buy
35,067
+14,525
+71% +$2.33M 0.1% 96
2020
Q1 		$1.83M Buy
+20,542
New +$1.27M 0.03% 138

Other funds holding INO

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sculptor Capital's INO Position: Q1 2022 in Review

Sculptor Capital sold out of Inovio Pharmaceuticals (INO) in Q1 2022, closing a stake of 59,475 shares — an estimated $3.56M sold.

Sculptor Capital first reported a position in INO in Q1 2020 and held it in 8 quarters. The position peaked at $8.31M in Q2 2020. 198 funds tracked by Wall St. Rank hold INO as of Q1 2022.

  • Sculptor Capital reported no remaining Inovio Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Sculptor Capital sold 59,475 Inovio Pharmaceuticals shares in Q1 2022, an estimated $3.56M.
  • Sculptor Capital first reported a position in Inovio Pharmaceuticals in Q1 2020 and held it in 8 quarters.
  • Sculptor Capital's Inovio Pharmaceuticals position peaked at $8.31M in Q2 2020.
  • 198 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2022.

Based on Sculptor Capital's 13F filing for Q1 2022, filed 13 May 2022.